Should you buy IMDX stock?
Last updated:
Based on market data through , StockInvest.us rates Insight Molecular Diagnostics Inc. (IMDX) as a Sell Candidate with a technical score of -2.71 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Down 4.60%
- 3-month trend forecast Down 21.82%
- +82.8% price growth over the last year
- Strong return on equity of 271.8%
- Highly efficient cash conversion (109% FCF/OCF ratio)
Red day on Monday for Insight Molecular Diagnostics Inc.
(Market data through Aug 10, 2026)
The Insight Molecular Diagnostics Inc. stock price fell by -1.24% on the last day (Monday, 10th Aug 2026) from $4.83 to $4.77. During the last trading day the stock fluctuated 3.16% from a day low at $4.75 to a day high of $4.90. The price has been going up and down for this period, and there has been a 1.49% gain for the last 2 weeks. Volume has increased on the last day by 32 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 73 thousand shares were bought and sold for approximately $349.44 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -21.82% during the next 3 months and, with a 90% probability hold a price between $3.26 and $4.26 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
IMDX Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 9.15%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Insight Molecular Diagnostics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.89 and $5.01. A break-up above any of these levels will issue buy signals. Insight Molecular Diagnostics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Insight Molecular Diagnostics Inc. stock
Insight Molecular Diagnostics Inc. finds support from accumulated volume at $4.71 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.150 between high and low, or 3.16%. For the last week, the stock has had daily average volatility of 5.97%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (IMDX) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Insight Molecular Diagnostics Inc. to open at $4.81, and during the day (based on 14 day Average True Range), to move between $4.60 and $4.94, which gives a possible trading interval of +/-$0.349 (+/-7.59%) up or down from last closing price. If Insight Molecular Diagnostics Inc. takes out the full calculated possible swing range there will be an estimated 7.59% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $4.79 (0.42%) than the support at $4.71 (1.26%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Insight Molecular Diagnostics Inc. stock A Buy?
Insight Molecular Diagnostics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-2.708
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $4.81 ( 0.769%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
IMDX Performance
Trading levels for IMDX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.96 | 3.91% |
| R2 | 4.90 | 2.71% |
| R1 | 4.86 | 1.97% |
| Price | 4.77 | |
| S1 | 4.75 | -0.433% |
| S2 | 4.71 | -1.17% |
| S3 | 4.66 | -2.38% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 5.44 | 14.05% |
| R2 | 5.32 | 11.53% |
| R1 | 4.79 | 0.419% |
| Price | 4.77 | |
| S1 | 4.71 | -1.26% |
| S2 | 4.59 | -3.77% |
| S3 | 4.46 | -6.50% |
FAQ
Click here for our free guide on how to buy Insight Molecular Diagnostics Inc. Stock.
Buy IMDX